165 related articles for article (PubMed ID: 37845622)
1. Evaluation of rs10811661 polymorphism in CDKN2A / B in colon and gastric cancer.
Beihaghi M; Sahebi R; Beihaghi MR; Nessiani RK; Yarasmi MR; Gholamalizadeh S; Shahabnavaie F; Shojaei M
BMC Cancer; 2023 Oct; 23(1):985. PubMed ID: 37845622
[TBL] [Abstract][Full Text] [Related]
2. Association between type 2 diabetes and CDKN2A/B: a meta-analysis study.
Bao XY; Xie C; Yang MS
Mol Biol Rep; 2012 Feb; 39(2):1609-16. PubMed ID: 21625859
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.
Ghobadi N; Mehramiz M; ShahidSales S; Rezaei Brojerdi A; Anvari K; Khazaei M; Rezayi M; Sadegh Khorrami M; Joudi-Mashhad M; Ramshini H; Ahmadi-Simab S; Moradi A; Hassanian SM; Ghayour-Mobarhan M; Boroushaki MT; Ferns GA; Avan A
J Cell Physiol; 2019 Apr; 234(4):5070-5076. PubMed ID: 30238987
[TBL] [Abstract][Full Text] [Related]
4. A genetic variant in CDKN2A/B gene is associated with the increased risk of breast cancer.
ShahidSales S; Mehramiz M; Ghasemi F; Aledavood A; Shamsi M; Hassanian SM; Ghayour-Mobarhan M; Avan A
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28276595
[TBL] [Abstract][Full Text] [Related]
5. Interaction between a variant of CDKN2A/B-gene with lifestyle factors in determining dyslipidemia and estimated cardiovascular risk: A step toward personalized nutrition.
Mehramiz M; Ghasemi F; Esmaily H; Tayefi M; Hassanian SM; Sadeghzade M; Sadabadi F; Moohebati M; Azarpazhooh MR; Parizadeh SMR; Heidari-Bakavoli A; Safarian M; Nematy M; Ebrahimi M; Ryzhikov M; Ferns GA; Ghayour-Mobarhan M; Avan A
Clin Nutr; 2018 Feb; 37(1):254-261. PubMed ID: 28065479
[TBL] [Abstract][Full Text] [Related]
6. Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B.
Hribal ML; Presta I; Procopio T; Marini MA; Stančáková A; Kuusisto J; Andreozzi F; Hammarstedt A; Jansson PA; Grarup N; Hansen T; Walker M; Stefan N; Fritsche A; Häring HU; Pedersen O; Smith U; Laakso M; Sesti G;
Diabetologia; 2011 Apr; 54(4):795-802. PubMed ID: 21234743
[TBL] [Abstract][Full Text] [Related]
7. CDC123/CAMK1D gene rs12779790 polymorphism and rs10811661 polymorphism upstream of the CDKN2A/2B gene in women with gestational diabetes.
Tarnowski M; Malinowski D; Safranow K; Dziedziejko V; Pawlik A
J Perinatol; 2017 Apr; 37(4):345-348. PubMed ID: 28079868
[TBL] [Abstract][Full Text] [Related]
8. The relationship between five widely-evaluated variants in CDKN2A/B and CDKAL1 genes and the risk of type 2 diabetes: a meta-analysis.
Peng F; Hu D; Gu C; Li X; Li Y; Jia N; Chu S; Lin J; Niu W
Gene; 2013 Dec; 531(2):435-43. PubMed ID: 24012816
[TBL] [Abstract][Full Text] [Related]
9. Association between type 2 diabetes and rs10811661 polymorphism upstream of CDKN2A/B: a meta-analysis.
Li H; Tang X; Liu Q; Wang Y
Acta Diabetol; 2013 Oct; 50(5):657-62. PubMed ID: 22623142
[TBL] [Abstract][Full Text] [Related]
10. Functional Genetic Single-Nucleotide Polymorphisms (SNPs) in Cyclin-Dependent Kinase Inhibitor 2A/B (CDKN2A/B) Locus Are Associated with Risk and Prognosis of Osteosarcoma in Chinese Populations.
Zhang H; Mao JS; Hu WF
Med Sci Monit; 2019 Feb; 25():1307-1313. PubMed ID: 30774116
[TBL] [Abstract][Full Text] [Related]
11. Variants of CDKAL1 rs7754840 (G/C) and CDKN2A/2B rs10811661 (C/T) with gestational diabetes: insignificant association.
Noury AE; Azmy O; Alsharnoubi J; Salama S; Okasha A; Gouda W
BMC Res Notes; 2018 Mar; 11(1):181. PubMed ID: 29544538
[TBL] [Abstract][Full Text] [Related]
12. Tagging rs10811661 variant at CDKN2A/2B locus is not associated with type 2 diabetes mellitus in Czech population.
Hubáček JA; Neškudla T; Klementová M; Adámková V; Pelikánová T
Folia Biol (Praha); 2013; 59(4):168-71. PubMed ID: 24093775
[TBL] [Abstract][Full Text] [Related]
13. FTO, GCKR, CDKAL1 and CDKN2A/B gene polymorphisms and the risk of gestational diabetes mellitus: a meta-analysis.
Guo F; Long W; Zhou W; Zhang B; Liu J; Yu B
Arch Gynecol Obstet; 2018 Oct; 298(4):705-715. PubMed ID: 30074065
[TBL] [Abstract][Full Text] [Related]
14. Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort.
Wen J; Rönn T; Olsson A; Yang Z; Lu B; Du Y; Groop L; Ling C; Hu R
PLoS One; 2010 Feb; 5(2):e9153. PubMed ID: 20161779
[TBL] [Abstract][Full Text] [Related]
15. Replication study of common variants in CDKAL1 and CDKN2A/2B genes associated with type 2 diabetes in Lebanese Arab population.
Nemr R; Almawi AW; Echtay A; Sater MS; Daher HS; Almawi WY
Diabetes Res Clin Pract; 2012 Feb; 95(2):e37-40. PubMed ID: 22119613
[TBL] [Abstract][Full Text] [Related]
16. Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population.
Wu Y; Li H; Loos RJ; Yu Z; Ye X; Chen L; Pan A; Hu FB; Lin X
Diabetes; 2008 Oct; 57(10):2834-42. PubMed ID: 18633108
[TBL] [Abstract][Full Text] [Related]
17. Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility.
Wang X; Li W; Ma L; Gao J; Liu J; Ping F; Nie M
Acta Diabetol; 2015 Oct; 52(5):951-8. PubMed ID: 25990668
[TBL] [Abstract][Full Text] [Related]
18. Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population.
Lee YH; Kang ES; Kim SH; Han SJ; Kim CH; Kim HJ; Ahn CW; Cha BS; Nam M; Nam CM; Lee HC
J Hum Genet; 2008; 53(11-12):991-998. PubMed ID: 18991055
[TBL] [Abstract][Full Text] [Related]
19. Association of cyclin-dependent kinase inhibitor 2A/B with increased risk of developing breast cancer.
Seifi S; Pouya F; Rahmani M; Mehramiz M; Rastgar-Moghadam A; Gharib M; Rahmani F; Shahidsales S; Hassanian SM; Khazaei M; Dadjoo P; Parvin SS; Yazdinezhad Y; Parizadeh SMR; Ferns GA; Fathi M; Avan A
J Cell Physiol; 2020 Jun; 235(6):5141-5145. PubMed ID: 31721206
[TBL] [Abstract][Full Text] [Related]
20.
Kong Y; Sharma RB; Ly S; Stamateris RE; Jesdale WM; Alonso LC
Diabetes; 2018 May; 67(5):872-884. PubMed ID: 29432124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
